| Financial Year |
March 31 2023 |
| Monetary Funds |
207,204,066.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
107,109,327.16 |
| Accounts Receivable |
230,168,731.73 |
| Advances to Suppliers |
2,221,165.19 |
| Other Receivables |
5,133,868.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
181,600,968.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,165,022.17 |
| Total Current Assets |
789,154,880.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,223,799.70 |
| Investment Properties |
-- |
| Fixed Assetes |
464,809,235.03 |
| Under-construction Projects |
12,312,792.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,616,372.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,327,332.66 |
| Deferred Income Tax Assets |
3,689,811.73 |
| Other Non-Current Assets |
2,483,664.93 |
| Sub-Total of Non-Current Assets |
618,512,942.72 |
| Total Assets |
1,407,667,823.41 |
| Short-Term Loans |
27,751,879.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
191,384,643.71 |
| Accounts Payable |
247,421,107.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,699,380.71 |
| Taxes Payable |
3,471,073.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,450,905.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,870,558.67 |
| Other Current Liabilities |
42,685.89 |
| Sub-Total of Current Liabilities |
531,423,271.22 |
| Long-term Loans |
6,520,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,783,289.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
41,662,822.07 |
| Total Liabilities |
573,086,093.29 |
| Paid-In Capital(Or Share Stock) |
252,426,948.00 |
| Capital Surplus |
1,037,763,904.31 |
| Surplus Reserve |
33,499,029.18 |
| LESS:Treasury Stock |
30,474,269.53 |
| Undistributed Profits |
-464,760,879.06 |
| Minority Stockholder's Interest |
6,126,468.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
828,455,261.83 |
| Owner's Equity（Stockholder's Equity） |
834,581,730.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,407,667,823.41 |
